Enrico Proietti

Istituto Superiore di Sanità — Italy

Immunology and Microbiology · Life Sciences

39h-index6.4kcitations188works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(69), Immune Cell Function and Interaction(53), Cytokine Signaling Pathways and Interactions(36), Monoclonal and Polyclonal Antibodies Research(27), T-cell and B-cell Immunology(24)

Publications187 total

Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha
Frontiers in Oncology·2023· 3 citedOpen Access
Supplementary Figure 2 from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Data from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Supplementary Figure 2 from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Supplementary Figure 1 from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Supplementary Table 1 from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Supplementary Figure 1 from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Supplementary Table 1 from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Supplementary figures legend from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Supplementary Figure 3 from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Supplementary figures legend from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Data from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Supplementary Figure 3 from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
2023Open Access
Supplementary Table 3 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Figure 1 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Figure Legend from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Figure 2 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Table 2 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Data from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Table 3 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Filippo Belardelli(37), Laura Bracci(13), Paola Sestili(13), Federica Moschella(11), Ion Gresser(8), Imerio Capone(6), Eleonora Aricò(6), Antonella Sistigu(5), Lucia Gabriele(5), Mara Valentini(5), Maria Ferrantini(5), Massimo Venditti(5), Massimo Spada(5), G. Carpinelli(5), Franca Podo(5), Valentina La Sorsa(4), Francesca Urbani(4), Laurence Zitvogel(4), Giovanna Schiavoni(4), M. Di Vito(4)